Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ketamine petition receives over 3,000 signatures
Stray dog
Ketamine is critical for control of zoonotic diseases like rabies.
Proposal to reschedule drug to be considered this week 

A WSAVA petition calling for ketamine not to be placed under international control has received over 3,000 signatures.

In 2014, China proposed to reclassify the drug to Schedule 1 following widespread misconception that it is only a ‘recreational drug’.

Yet a review by the World Health Organisation (WHO) concluded that ketamine abuse does not pose a global public health threat, and that such control would limit access to those who most need it as a life-saving anaesthetic.

This week, delegates at the 29th UN Convention on Narcotic Drugs (CND) (14-22 March, Vienna) will meet to decide between the two opposite proposals.

In an open letter, the WSAVA urge the CND to follow the recommendations of the WHO. In it they write:

“The proposal for international control stems from the widespread misconception that it is only a 'recreational drug.' This is an inaccurate view and devalues the contribution that ketamine makes to to human and animal health. The WSAVA believes that it is an essential medicine.

“Ketamine is a remarkably safe anaesthetic which has been used worldwide for more than 50 years. It does not depress respiration or the circulation.  It can be used without oxygen, ventilators and electricity supply and support systems required for other anaesthetics.  

“These characteristics make it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries.”

As well as having particular value ‘in the field’ - for trauma, traffic and sporting injuries, ketamine is the most common and often only product for steralization initiatives. It also plays a huge role in feral cat/dog populations and is critical for control of zoonotic diseases like rabies.

The WSAVA conclude: “The WSAVA believes that medical and veterinary professionals should continue to have access to ketamine under the current scheduling controls and calls on concerned individuals to support our campaign to allow access to this essential medicine.”

To support the campaign and sign the petition visit: www.change.org.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com